Evidence map›Paper›PMID 27143420›Full record

ArticleNeurobiology of aging2016

Presenilin 1 promotes trypsin-induced neuroprotection via the PAR2/ERK signaling pathway. Effects of presenilin 1 FAD mutations.

Angeliki M Nikolakopoulou, Anastasios Georgakopoulos, Nikolaos K Robakis

Abstract read
In one paragraph

Article in Neurobiology of aging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Non-coding RNA influences in dementia.Non-coding RNA research · 2018
    Review
  7. Review
  8. Article
  9. Review
  10. The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility.International journal of molecular sciences · 2017
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Angeliki M NikolakopoulouDepartment of Psychiatry, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Neuroscience, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: nikolako@med.usc.edu.
Anastasios GeorgakopoulosDepartment of Psychiatry, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Neuroscience, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nikolaos K RobakisDepartment of Psychiatry, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Neuroscience, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: Nikos.robakis@mssm.edu.
Icahn School of Medicine at Mount Sinai · US

Funding

Regulation of ephrinB2-dependent angiogenesis by PS1 in normal and ADR01NS047229 · NINDS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GEORGAKOPOULOS, ANASTASIOS, ROBAKIS, NIKOLAOS K · 2004 to 2025
$8.3M
STRUCTURE &EXPRESSION OF THE B-PROTEIN-PRECURSOR GENER01AG008200 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI ROBAKIS, NIKOLAOS K · 1988 to 2017
$5.6M
PS1 regulates processing and signaling of ephrinB/EphBR37AG017926 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI ROBAKIS, NIKOLAOS K · 2005 to 2014
$3.3M
Effects of PS1FAD mutations on PS1-NMDAR association, necroptosis and electrophysiology.RF1AG008200 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ROBAKIS, NIKOLAOS K · 2018 to 2018
$2.8M
Presenilin1/gamma-secretase regulate the VEGFA/VEGFR2 brain angiogenesis inhibited by FAD mutants.R56AG008200 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GEORGAKOPOULOS, ANASTASIOS, ROBAKIS, NIKOLAOS K · 2023 to 2023
$835k
NIA NIH HHS R01 AG008200NIA NIH HHS R37 AG017926NIA NIH HHS R56 AG008200NIA NIH HHS RF1 AG008200NINDS NIH HHS R01 NS047229
6 · The paper itself

Abstract

Mutants of presenilin 1 (PS1) increase neuronal cell death causing autosomal-dominant familial Alzheimer's disease (FAD). Recent literature shows that treatment of neuronal cultures with low concentrations of trypsin, a member of the serine family of proteases, protects neurons from toxic insults by binding to the proteinase-activated receptor 2 and stimulating survival kinase extracellular signal-regulated kinase (ERK 1/2). Other studies show that PS1 is necessary for the neuroprotective activity of specific neurotrophic factors, such as brain-derived neurotrophic factor, against excitotoxicity and oxidative stress. Here, we show that treatment of mouse cortical neuronal cultures with trypsin activates ERK1/2 and protects neurons against glutamate excitoxicity. The trypsin-dependent ERK activation and neuroprotection requires both alleles of PS1 because neither PS1 knockout nor PS1 hemizygous neuronal cultures can use exogenous trypsin to activate ERK1/2 or increase neuronal survival. The protective effect of PS1 does not depend on its γ-secretase activity because inhibitors of γ-secretase have no effect on trypsin-mediated neuroprotection. Importantly, cortical neuronal cultures either heterozygous or homozygous for PS1 FAD mutants are unable to use trypsin to activate ERK1/2 and rescue neurons from excitotoxicity, indicating that FAD mutants inhibit trypsin-dependent neuroprotection in an autosomal-dominant manner. Furthermore, our data support the theory that PS FAD mutants increase neurodegeneration by inhibiting the ability of neurons to use cellular factors as protective agents against toxic insults.

Indexed as

MutationNeuroprotective AgentsAlzheimer DiseaseCell DeathCells, CulturedCell SurvivalCerebral CortexHumansMAP Kinase Signaling SystemNeuronsOxidative StressPresenilin-1TrypsinNeuroprotective AgentsPresenilin-1TrypsinFamilial Alzheimer's diseaseNeuroprotectionNeurotoxicityPresenilin 1Proteinase-activated receptor 2

Identifiers

PMID27143420
PMCPMC4857890
OpenAlexW2291041324

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.